Impact of Risk-Reducing Salpingo-Oophorectomy on BRCA1/2 Female Carriers Diagnosed with Early Breast Cancer

被引：0
|
作者：
Meireles, P. Antunes [1 ]
Fragoso, S. [2 ]
Santos, S. [2 ]
Duarte, T. [2 ]
Lopez, B. [3 ]
Correia, L. [1 ,3 ]
Miguel, I.
Rodrigues, P. [4 ]
Vaz, F. [1 ,2 ]
机构：
[1] Inst Portugues Oncol Francisco Gentil, Med Oncol, Lisbon, Portugal
[2] Inst Portugues Oncol Francisco Gentil, Mol Pathobiol Res Unit, Lisbon, Portugal
[3] Inst Portugues Oncol Francisco Gentil, Gynecol, Lisbon, Portugal
[4] Inst Portugues Oncol Francisco Gentil, Familial Canc Clin, Lisbon, Portugal
来源：
BREAST | 2025年 / 80卷
关键词：
D O I：
10.1016/j.breast.2025.104013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P159
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Incidental early occult ovarian cancer after risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers followed in a community public hospital
    Grana Suarez, B.
    Molina, A.
    Prato, J.
    Czestokowa, C.
    Conde, C.
    Reboredo Rendo, C.
    Quindos, M.
    Perez, E.
    Lesta Mellid, R.
    Cordeiro, P.
    Gomez-Randulfe, I.
    Antolin, S.
    Calvo, L.
    ANNALS OF ONCOLOGY, 2019, 30
  • [42] PREDICTORS OF CANCER PRECURSOR LESIONS IN BRCA MUTATION CARRIERS UNDERGOING RISK-REDUCING SALPINGO-OOPHORECTOMY
    Bradbury, M.
    Cabrera, S.
    Garcia, A.
    Sanchez-Iglesias, J. L.
    Perez-Benavente, A.
    Gil-Moreno, A.
    Santamaria, A.
    de la Torre, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 931 - 931
  • [43] Uptake and timing of risk-reducing salpingo-oophorectomy among patients with BRCA1 and BRCA2 mutations
    Smith, Maria J.
    Gerber, Deanna
    Olsen, Anne
    Khouri, Olivia R.
    Wang, Yuyan
    Liu, Mengling
    Smith, Julia
    Pothuri, Bhavana
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2021, 225 (05)
  • [44] Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers
    Rebbeck, Timothy R.
    Kauff, Noah D.
    Domchek, Susan M.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (02): : 80 - 87
  • [45] PREDICTORS OF CANCER PRECURSOR LESIONS IN BRCA MUTATION CARRIERS UNDERGOING RISK-REDUCING SALPINGO-OOPHORECTOMY
    Bradbury, M.
    Cabrera, S.
    Garcia, A.
    Sanchez-Iglesias, J. L.
    Perez-Benavente, A.
    Gil-Moreno, A.
    Santamaria, A.
    de la Torre, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 166 - 166
  • [46] Uptake Rate of Risk-Reducing Salpingo-Oophorectomy and Surgical Outcomes of Female Germline BRCA1/2 Mutation Carriers: A Retrospective Cohort Study
    Lim, Hyunji
    Kim, Se Ik
    Hyun, Sowoon
    Lee, Gwang Bin
    Seol, Aeran
    Lee, Maria
    YONSEI MEDICAL JOURNAL, 2021, 62 (12) : 1090 - 1097
  • [47] Hormone replacement therapy after prophylactic risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers: A meta-analysis
    Marchetti, C.
    De Felice, F.
    Boccia, S.
    Sassu, C.
    Di Donato, V.
    Perniola, G.
    Palaia, I.
    Monti, M.
    Muzii, L.
    Tombolini, V.
    Panici, P. Benedetti
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 132 : 111 - 115
  • [48] Bilateral Salpingo-oophorectomy and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Assessing the Evidence
    Conduit, Ciara
    Milne, Roger L.
    Friedlander, Michael L.
    Phillips, Kelly-Anne
    CANCER PREVENTION RESEARCH, 2021, 14 (11) : 983 - 993
  • [49] Quality of life in BRCA1 and BRCA2 mutation carriers (B1/2) following risk-reducing salpingo-oophorectomy (RRSO).
    Domchek, Susan M.
    Li, Jiaqi
    Digiovanni, Laura
    Voong, Chan
    Mueller, Rebecca
    Johnson, Lauren
    Epperson, C. Neill
    Friedman, Sue
    Gracia, Clarisa
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [50] Uptake of risk-reducing salpingo-oophorectomy among female BRCA mutation carriers: experience at the National Cancer Center of Korea
    Kim, Se Ik
    Lim, Myong Cheol
    Lee, Dong Ock
    Kong, Sun-Young
    Seo, Sang-Soo
    Kang, Sokbom
    Lee, Eun Sook
    Park, Sang-Yoon
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (01) : 333 - 340
12345